Fatigue in Multiple Sclerosis Is Associated with Reduced Expression of Interleukin-10 and Worse Prospective Disease Activity
Authors:
- Luana GilioLGLuana Gilio
- Fabio ButtariFBFabio Buttari
- Luigi PavoneLPLuigi Pavone
- Ennio IezziEIEnnio Iezzi
- Giovanni GalifiGGGiovanni Galifi
- Ettore DolcettiEDEttore Dolcetti
- Federica AzzoliniFAFederica Azzolini
- Antonio BrunoABAntonio Bruno
- Angela BorrelliABAngela Borrelli
- Marianna StortoMSMarianna Storto
- Roberto FurlanRFRoberto Furlan
- Annamaria FinardiAFAnnamaria Finardi
Open Access
- 23 August 2022
- journal article
- research article
- Published by MDPI AG in Biomedicines
- Vol. 10 (9) , 2058
Abstract
In multiple sclerosis (MS), fatigue is a frequent symptom that negatively affects quality of life. The pathogenesis of fatigue is multifactorial and inflammation may play a specific role. To explore the association between fatigue, central inflammation and disease course in MS in 106 relapsing-remitting (RR)-MS patients, clinical characteristics, including fatigue and mood, were explored at the time of diagnosis. NEDA (no evidence of disease activity)-3 status after one-year follow up was calculated. Cerebrospinal fluid (CSF) levels of a set of proinflammatory and anti-inflammatory molecules and peripheral blood markers of inflammation were also analyzed. MRI structural measures were explored in 35 patients. A significant negative correlation was found at diagnosis between fatigue measured with the Modified Fatigue Impact Scale (MFIS) and the CSF levels of interleukin (IL)-10. Conversely, no significant associations were found with peripheral markers of inflammation. Higher MFIS scores were associated with reduced probability to reach NEDA-3 status after 1-year follow up. Finally, T2 lesion load showed a positive correlation with MFIS scores and a negative correlation with CSF IL-10 levels at diagnosis. CSF inflammation, and particularly the reduced expression of the anti-inflammatory molecule IL-10, may exacerbate fatigue. Fatigue in MS may reflect subclinical CSF inflammation, predisposing to greater disease activity.Keywords
Funding Information
- Ministero della Salute (Ministry of Health, Italy) (RF-2018-12366144, GR-2018-12366154, 2019/S/1, 2020/R-Multi/018)
- Fondazione Italiana Sclerosi Multipla (FISM) (RF-2018-12366144, GR-2018-12366154, 2019/S/1, 2020/R-Multi/018)
- Fondazione Italiana Sclerosi Multipla (FISM) (RF-2018-12366144, GR-2018-12366154, 2019/S/1, 2020/R-Multi/018)
- Private donation in memory of Chiara Sardi to Diego Centonze (RF-2018-12366144, GR-2018-12366154, 2019/S/1, 2020/R-Multi/018)
- FOE 2020 (RF-2018-12366144, GR-2018-12366154, 2019/S/1, 2020/R-Multi/018)
This publication has 44 references indexed in Scilit:
- Mitochondrial dysfunctions in Myalgic Encephalomyelitis / chronic fatigue syndrome explained by activated immuno-inflammatory, oxidative and nitrosative stress pathwaysMetabolic Brain Disease, 2013
- Fatigue in Systemic Lupus Erythematosus and Rheumatoid ArthritisPM&R, 2010
- Fatigue Is Not Associated with Impaired Function of Regulatory T Cells in Untreated Patients with Multiple SclerosisEuropean Neurology, 2009
- Effect of natalizumab on clinical and radiological disease activity in multiple sclerosis: a retrospective analysis of the Natalizumab Safety and Efficacy in Relapsing-Remitting Multiple Sclerosis (AFFIRM) studyThe Lancet Neurology, 2009
- Fatigue in multiple sclerosis is associated with the disruption of frontal and parietal pathwaysMultiple Sclerosis Journal, 2009
- Longitudinal correlates of fatigue in multiple sclerosisMultiple Sclerosis Journal, 2008
- Correlation between fatigue and brain atrophy and lesion load in multiple sclerosis patients independent of disabilityJournal of the Neurological Sciences, 2007
- Fatigue in multiple sclerosis: an example of cytokine mediated sickness behaviour?Journal of Neurology, Neurosurgery & Psychiatry, 2006
- Modalities of fatigue in multiple sclerosis: correlation with clinical and biological factorsMultiple Sclerosis Journal, 2000
- Rating neurologic impairment in multiple sclerosisNeurology, 1983